McKesson (NYSE:MCK) Rating Upgrade

JPMorgan raised the shares of Mckesson (NYSE:MCK) from a “Neutral” rating to “Overweight” rating in a research note issued to clients and investors on Tuesday morning.

In spite of this rating upgrade NYSE:MCK is right now trading 0.00% lower at $155.42 as of 2:04 AM New York time. McKesson shares have [From2] 0% in the past 200 days, while the S&P500 has added 6.00% during the same time.

Out of 15 analysts covering McKesson, 11 rate it a Buy, 7 indicate a Hold while 0 suggest a Sell. The highest target is $220 and the lowest is $164 according to Thomson/First Call. The 12-month mean target is $195.93, which means upside potential of 26.06% over the current price.

Institutional Ownership

Southpoint Capital Advisors Lp had the biggest stake with ownership of 1.25 million shares as of q2 2015 for 9.31% of the long Stock exposure. Kdi Capital Partners Llc is another very bullish investment manager who is possessing 145,459 shares of McKesson or 9.3% of their long stock exposure. Further, North Run Capital Lp have 6.55% of their long stock exposure invested in the company for 250,000 shares. The California-based fund Meritage Group Lp revealed it had bought a stake worth about 4.86% of the investment manager’s stock portfolio in McKesson. The California-based fund Scharf Investments Llc is also positive about the stock, possessing 1.11 million shares or 4.33% of their long stock exposure.

McKesson (NYSE:MCK) Profile

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

McKesson (NYSE:MCK) closed at $155.42 yesterday. A total of 159 shares of the company’s stock traded hands. This is down from average of 1.85M shares. McKesson has a 52 week low of $114.53 and a 52 week high of $199.43. The company has a market cap of $33.48B and a P/E ratio of 6.51.

Get the latest McKesson (NYSE:MCK) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post JPMorgan Increases McKesson (NYSE:MCK) to “Overweight” From “Neutral” Stock Rating appeared first on Octafinance.